Answers are grounded in this paper and cite their sources.
Each therapeutic agent, as monotherapy, increased 2- to 3-fold the proportion of patients who attained HbA1c below 7% compared with diet alone. However, the progressive deterioration of diabetes control was such that after 3 years approximately 50% of patients could attain this goal with monotherapy, and by 9 years this declined to approximately 25%. The majority of patients need multiple therapies to attain these glycemic target levels in the longer term.
No takes yet. Share an insight, caveat, or question.
Robert C. Turner (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: